CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours
Authors
A Ashkenazi
A Ashkenazi
+42Â more
C-P Huang
D Branstetter
D Micha
D Sarker
E Dean
E Ulukaya
EC de Haas
F Durrieu
G Kramer
G Pan
GA Roth
H Walczak
J Cummings
JG Emery
JP Sheridan
JW Lee
K Biven
M Peach
MA Degli-Esposti
MA Degli-Esposti
MH Olofsson
MH Olofsson
MS Lippa
NO Ku
P M Holland
R S Herbst
R Xu
RM Pitti
RS Herbst
S G Eckhardt
S Linder
SA Leon
SA Marsters
SJ Zoog
SK Kelley
SR Wiley
SW Fesik
T Stigbrand
TH Ward
W Novotny
Y Pan
Y Yilmaz
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1038%2Fbjc.2011.45...
Last time updated on 03/12/2019